-
European Radiology 03/2011; · 3.22 Impact Factor
-
[show abstract]
[hide abstract]
ABSTRACT: Coronary angiography using multidetector computed tomography (MDCT) allows non-invasive assessment of non-calcified, calcified and mixed plaques. Progression of coronary plaques may be influenced by statins.
Sixty-three consecutive patients underwent MDCT as a follow-up to their original CT angiography in a retrospective longitudinal study. MDCT was performed by using a voxel size of 0.5 × 0.35 × 0.35 mm(3) at two time points 25 ± 3 months apart. Non-calcified, calcified and mixed coronary plaque components were analysed by using volumetric measurement. The influence of statin, low-density lipoprotein (LDL) and risk factors was assessed by using a linear random intercept model for plaque growth.
The volumes of non-calcified, calcified and mixed coronary plaques significantly (P < 0.001) increased from baseline (medians/interquartile ranges = 21/15-39, 7/3-20 and 36/16-69 mm(3)) to follow-up (29/17-44, 13/6-29 and 41/20-75 mm(3)). Statins significantly slowed the growth of non-calcified plaques (statin coefficient β = -0.0036, P = 0.01) but did not significantly affect the growth rate of mixed or calcified plaques. The effect of statin treatment on non-calcified plaques remained significant after adjusting for LDL levels and cardiac risk factors.
Quantification using MDCT shows that progression of non-calcified coronary plaques may be slowed by statins.
European Radiology 12/2010; 20(12):2824-33. · 3.22 Impact Factor
-
[show abstract]
[hide abstract]
ABSTRACT: To examine differences in body size estimation in adolescents with different types of eating disorders.
A total of 129 patients with eating disorders (M(age) = 16.0 +/- 1.8) and 354 healthy control participants (CP) (M(age) = 15.2 +/- 2.1) completed the EDI-2 and were asked to estimate the circumference of selected body parts by using string (BID-CA).
CP showed an average overestimation of 8-16%, depending on the estimated body part. Eating disorder patients overestimated their body parts on average by about 30%. Thigh and waist estimations were the best variables for discriminating between patients with eating disorders and CP. No significant differences were found between bulimia nervosa and anorexia nervosa patients.
Body image distortion plays an important role in both anorexia nervosa and bulimia nervosa. The BID-CA is well suited to discriminate between healthy and disordered overestimation of body parts.
European Eating Disorders Review 11/2009; 17(6):468-75. · 1.38 Impact Factor
-
[show abstract]
[hide abstract]
ABSTRACT: Intracranial hypertension, defined as intracranial pressure (ICP) >/= 20 mm Hg, is a complication typically associated with head injury. Its impact on cerebral metabolism, ICP therapy, and outcome has rarely been studied in patients with aneurysmal subarachnoid hemorrhage (aSAH); such an assessment is the authors' goal in the present study.
Cerebral metabolism was prospectively studied in 182 patients with aSAH. The database was retrospectively analyzed with respect to ICP. Patients were classified into 2 groups based on ICP. There were 164 with low ICP (<20 mm Hg) and 18 with high ICP (>or=20 mm Hg, measured>6 hours/day). Cerebral microdialysis parameters of energy metabolism, glycerol, and glutamate levels were analyzed hourly from the brain parenchyma of interest for 7 days. The 12-month outcome in these patients was evaluated.
In the high ICP group, extended ICP therapy including decompressive craniectomy was necessary in 7 patients (39%). Cerebral glycerol levels and the lactate/pyruvate ratio were pathologically increased on Days 1-7 after aSAH (p<0.001). The excitotoxic neurotransmitter glutamate and glycerol, a marker of membrane degradation, further increased on Days 5-7, probably reflecting the development of secondary brain damage. An ICP>or=20 mm Hg was shown to have a significant influence on the 12-month Glasgow Outcome Scale (GOS) score (p=0.001) and was a strong predictor of mortality (OR=24.6; p<0.001). Glutamate (p=0.012), the lactate/pyruvate ratio as a marker of anaerobic metabolism (p=0.028), age (p<0.001), and Fisher grade (p=0.001) also influenced the GOS score at 12 months.
The authors confirmed the relevance of intracranial hypertension as a severe complication in patients with aSAH. Because high ICP is associated with a severely deranged cerebral metabolism and poor outcome, future studies focusing on metabolism-guided, optimized ICP therapy could help minimize secondary brain damage and improve prognosis in patients with aSAH.
Journal of Neurosurgery 03/2009; 111(1):94-101. · 2.96 Impact Factor
-
[show abstract]
[hide abstract]
ABSTRACT: Bacterial meningitis (BM) is a severe complication in patients with aneurysmal subarachnoid haemorrhage (SAH). Clinical signs of meningitis are often masked by SAH-related symptoms, and routine cerebrospinal fluid (CSF) analysis fails to indicate BM. Microdialysis (MD) is a technique for monitoring cerebral metabolism in patients with SAH. A cohort study was performed to investigate the value of MD for the diagnosis of BM.
Retrospectively, 167 patients with SAH in an ongoing investigation on cerebral metabolism monitored by MD were analysed for the presence of BM and related MD changes. Diagnosis of BM was based on microbiological CSF culture or clinical symptoms responding to antibiotic treatment, combined with an increased CSF cell count and/or fever. Levels of MD parameters before and after diagnosis of BM were analysed and compared with the spontaneous course in controls.
BM developed in 20 patients, of which 12 underwent MD monitoring at the time of diagnosis. A control group was formed using 147 patients with SAH not developing meningitis. On the day BM was diagnosed, cerebral glucose was lower compared with the value three days before (p = 0.012), and the extent of decrease was significantly higher than in controls (p = 0.044). A decrease in cerebral glucose by 1 mmol/L combined with the presence of fever >or= 38 degrees C indicated BM with a sensitivity of 69% and a specificity of 80%. CSF chemistry failed to indicate BM, but the cell count increased during the days before diagnosis (p < 0.05).
A decrease in MD glucose combined with the presence of fever detected BM with acceptable sensitivity and specificity, while CSF chemistry failed to indicate BM. In patients with SAH where CSF cell count is not available or helpful, MD might serve as an adjunct criterion for early diagnosis of BM.
Critical care (London, England) 01/2009; 13(1):R2. · 4.61 Impact Factor
-
[show abstract]
[hide abstract]
ABSTRACT: To assess the performance of the German version of the Anorectic Behavior Observation Scale (ABOS) as a parent-report screening instrument for eating disorders (ED) in their children.
Parents of 101 ED female patients (80 with Anorexia Nervosa; 21 with Bulimia Nervosa) and of 121 age- and socioeconomic status (SES)-matched female controls completed the ABOS.
Confirmatory factor analysis supported the original three-factor structure model of the ABOS. Cronbach's alpha coefficients indicated good internal consistency for the three factors and the total score in the total sample. The best cut-off point (100% sensitivity and specificity) in the German version was >or=23.
The ABOS may be a useful additional instrument for assessing ED.
European Child & Adolescent Psychiatry 01/2009; 18(5):321-5. · 2.82 Impact Factor
-
[show abstract]
[hide abstract]
ABSTRACT: Multislice computed tomography (MSCT) is an emerging noninvasive technique for detecting coronary plaques. The present study investigated agreement in the detection and characterization of coronary plaques and reproducibility of volumetric analysis.
A total of 20 patients underwent MSCT coronary angiography using 64 * 0.5 mm detector collimation. Two readers independently visually evaluated all MSCT datasets for the presence of coronary plaques (n = 82 in 262 coronary segments) and then classified them as calcified, mixed and noncalcified. In addition, one of the readers also manually determined total volumes as well as calcified and noncalcified volumes of each plaque. After a period of at least 4 weeks the complete volumetric analysis was repeated.
Interobserver agreement was good for detection of coronary plaques on the segment level (weighted kappa = 0.88, 95% CI [0.76, 0.95]). However, there was only moderate interobserver agreement for plaques classification (unweighted kappa = 0.45, 95% CI [0.35, 0.61]). Intraobserver agreement was good for plaque detection on segment level (weighted kappa = 0.90, 95% CI [0.77, 0.96]), while it was moderate with respect to their characterization (unweighted kappa = 0.65, 95% CI [0.55, 0.80]). There was moderate reproducibility for total plaque volume (limits of agreement = +/-6 mm3 at a mean measured volume of 10 mm3 and = +/-28 mm3 at a mean measured volume of 100 mm3). Variation of relative differences significantly decreased for total volume and noncalcified volume with increasing mean volume.
Detection and volumetry of plaques by means of MSCT shows good to moderate reproducibility. Agreement of volume measurements depends on plaque size. Variation of relative differences decrease with increasing mean plaque volume.
The International Journal of Cardiovascular Imaging 07/2008; 24(7):735-42. · 2.29 Impact Factor
-
[show abstract]
[hide abstract]
ABSTRACT: The larynx bypass (LB) is the only device capable of providing laryngectomy patients with the ability to smell. Our findings regarding one-time and long-term use did reveal an improved olfactory function in these patients. Because the LB is difficult to use, however, it is not appropriate for everyday use. Therefore, we devised a new instrument: the scent-diffusing ventilator (SV).
Between January 2006 and February 2007, we researched the olfactory function of 16 patients who had undergone a laryngectomy (13 men/3 women; median age, 63 years) by using the LB and the SV. Their olfactory function was measured with the Sniffin' Sticks test battery. Further practicability of both methods was determined through a visual analog scale (1-10).
The patients' olfactory function significantly improved (SV median 8 versus LB median 7; p < 0.002). In addition, the SV was much easier to use than the LB (median, 6 versus 5; p < 0.001).
Further technical improvements are necessary to make the SV an established part of the rehabilitation of the olfactory function after laryngectomy.
American Journal of Rhinology 22(5):487-90. · 1.36 Impact Factor
-
[show abstract]
[hide abstract]
ABSTRACT: The purpose of this study was to evaluate long-term outcomes of an outpatient-based diode laser inferior turbinate reduction (ITR) in therapy-refractory rhinitis medicamentosa (RM).
In a prospective clinical investigation, 42 consecutive RM patients underwent videoendoscopic ITR with a diode laser after topical anesthetic preparation. Intra- and perioperative details were recorded including the occurrence of bleeding, crusting, pain, or discomfort. Treatment efficiency was assessed by follow-ups 1 and 6 weeks as well as 6 and 12 months after surgery. Subjective pre- and posttherapeutic nasal airflow (NA) and patient satisfaction were rated on visual analog scales (VASs). Assessment of the long-term objective clinical effectiveness was based on rhinomanometry, IT photodocumentation, and the recurrent need for decongestants.
Preoperative addiction to decongestants lasted 5 +/- 2 years (mean +/- SD). There was no major bleeding requiring nasal packing, and there were no other perioperative complications. Postoperative edema disappeared within the 1st week and crusting within 6 weeks after surgery. VAS was characterized by very low values for intraoperative pain and discomfort and high postoperative patient satisfaction. After 6 months, NA data revealed a significant improvement of subjective VAS and objective rhinomanometry (250.4-413.9 cm3/s inspiration at 150 Pa). A total of 88% of patients managed to successfully stop decongestant abuse after 6 months (74% after 1 year).
In therapy-refractory RM, outpatient diode laser ITR of hyperplastic IT represents a highly effective, safe, and well-tolerated treatment option that provides long-lasting recovery by markedly improving NA and stopping addiction to nasal decongestants.
American Journal of Rhinology 22(4):433-9. · 1.36 Impact Factor
